Equity Plans

6 Months Ended

Feb. 29, 2024

Share-Based Payment Arrangement [Abstract]

As of February 29, 2024, 72 million shares of our common stock were available for future awards under our equity plans, including 12 million shares approved for issuance under our employee stock purchase plan (“ESPP”).

Restricted Stock and Restricted Stock Units (“Restricted Stock Awards”)

Restricted Stock Awards activity is summarized as follows:


Six months ended	February 29, 2024		March 2, 2023

Restricted stock award shares granted	12		14
Weighted-average grant-date fair value per share	$	67.78	$	54.00

Employee Stock Purchase Plan (“ESPP”)

For each six-month ESPP offering period that ended in the second quarter of 2024 and 2023, employees purchased 2 million and 3 million shares, respectively, at a share price of $60.68 and $52.45, respectively.

Stock-based Compensation Expense

Stock-based compensation expense recognized in our statements of operations is presented below. Stock-based compensation expense of $98 million and $88 million was capitalized and remained in inventory as of February 29, 2024 and August 31, 2023, respectively.


	Quarter ended				Six months ended
	February 29, 2024		March 2, 2023		February 29, 2024		March 2, 2023

Stock-based compensation expense by caption
Cost of goods sold	$	80	$	40	$	147	$	76
Research and development	77		59		145		112
Selling, general, and administrative	52		36		99		73
Restructure	—		(2)		—		(2)
	$	209	$	133	$	391	$	259

Stock-based compensation expense by type of award
Restricted stock awards	$	191	$	116	$	354	$	225
ESPP	18		17		37		34
	$	209	$	133	$	391	$	259

As of February 29, 2024, $1.69 billion of total unrecognized compensation costs for unvested awards, before the effect of any future forfeitures, was expected to be recognized through the second quarter of 2028, resulting in a weighted-average period of 1.3 years.